Anemia and the elderly: clinical considerations

被引:23
作者
Gabrilove, J [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA
关键词
erythropoietic; anemia; hemoglobin;
D O I
10.1016/j.beha.2005.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anemia is a common problem in the management of elderly patients. Anemia in the elderly is linked to an increase in morbidity and mortality, and serves as an independent variable associated with poor outcomes. In the elderly population, anemia is a risk factor for cardiovascular health and early death, contributes to fatigue, and negatively impacts on cognitive function, physical function, and the quality of life and serves as a marker of increased vulnerability. A greater understanding of pathophysiology of anemia in the setting of chronic disease has provided insights into the rationale for the potential clinical application of erythropoietic agents in the treatment of anemia. The impact of erythropoietic therapy, as it relates to specific afflictions affecting the older age patient, including diminished exercise tolerance, frailty, loss of functional capacity, immobility, depression, increased care needs and cardiovascular fitness, remains to be determined and is worthy of further investigation.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 33 条
[1]   Predisposing factors for delirium in the surgical intensive care unit [J].
Aldemir, M ;
Özen, S ;
Kara, IH ;
Sir, A ;
Baç, B .
CRITICAL CARE, 2001, 5 (05) :265-270
[2]  
Balducci L, 2000, ONCOLOGY-NY, V14, P221
[3]   Prevalence and outcomes of anemia in geriatrics:: A systematic review of the literature [J].
Beghé, C ;
Wilson, A ;
Ershler, WB .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 :3-10
[4]  
Cella D, 1998, SEMIN ONCOL, V25, P43
[5]   Neuroprotective properties of epoetin alfa [J].
Cerami, A ;
Brines, M ;
Ghezzi, P ;
Cerami, C ;
Itri, LM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :8-12
[6]   Effects of epoetin alfa on the central nervous system [J].
Cerami, A ;
Brines, ML ;
Ghezzi, P ;
Cerami, CJ .
SEMINARS IN ONCOLOGY, 2001, 28 (02) :66-70
[7]  
DALY MP, 1989, AM FAM PHYSICIAN, V39, P129
[8]  
Ershler WB, 2003, J AM GERIATR SOC, V51, pS18
[9]   Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty [J].
Ershler, WB ;
Keller, ET .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :245-270
[10]  
Evans WJ, 2002, ONCOLOGY-NY, V16, P109